Investigating genetic risks for aggressive thyroid cancer in male veterans
Official title: Genetic Risk for Aggressive Thyroid Cancer in an Understudied Male Predominant Veteran Population
Funded at VA Eastern Colorado Health Care System · NIH-10919300 · Data updated 2026-11-12
This study is looking at how genes and environmental factors, like exposure to toxins, affect aggressive thyroid cancer in veterans, especially men, to help find better ways to diagnose and treat this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Eastern Colorado Health Care System NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project start | October 1, 2024 |
| Project end | September 30, 2028 |
| Funding year | 2025 |
| NIH project number | 1I01BX006252-01A2 |
| Project ID | NIH-10919300 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are male veterans, particularly those with a family history of thyroid cancer or exposure to environmental toxins.
✕Less likely to help
Patients who are not veterans or who do not have a history of thyroid cancer or related risk factors may not benefit from this research.
What this research studies
This research focuses on understanding the genetic and environmental factors that contribute to aggressive thyroid cancer, particularly in a male-dominant population of veterans. By utilizing the Million Veteran Program, which includes over 950,000 enrolled veterans, the study aims to identify specific genetic markers and risk factors associated with this type of cancer. The research will analyze data from veterans, many of whom may have been exposed to environmental toxins like Agent Orange, to better understand how these factors influence cancer severity and outcomes. The ultimate goal is to improve personalized diagnosis and treatment options for those affected.
Why it matters
Potential benefit: If successful, this research could lead to more accurate risk assessments and tailored treatment strategies for aggressive thyroid cancer in veterans.
How similar studies have gone: While there is ongoing research into thyroid cancer, this specific focus on genetic risks in a male veteran population is relatively novel and has not been extensively studied.
Where this research is happening
-
VA Eastern Colorado Health Care System
Aurora, United States Active
Researchers
- Principal investigator: Fishbein, Lauren Michelle — VA Eastern Colorado Health Care System
- Study coordinator: Fishbein, Lauren Michelle
Related research
Other NIH-funded projects on the same topics.
-
WTC Dust and Thyroid Cancer Progression in Human Organoids
This grant tests how World Trade Center dust might influence thyroid cancer progression using human thyroid organoids to model real-life exposure.
-
Integrating molecular signals to guide thyroid cancer care
A doctor-scientist team at Brigham and Women’s Hospital is studying how tumor biology and the immune environment can guide personalized monitoring and treatment for differentiated thyroid cancer.
-
Metabolic Imaging to Track Treatment Response in Aggressive Thyroid Cancer
This grant explores a new way to watch how aggressive thyroid cancers respond to treatment using a special MRI technique that tracks tumor metabolism.
-
Adoptive T-cell Therapy for Anaplastic Thyroid Cancer
A patient-focused program explores using patient immune cells engineered to target and fight anaplastic thyroid cancer, especially for those whose cancer has stopped responding to standard treatments.
-
Overcoming Resistance to BRAF Inhibitors in Aggressive Thyroid Cancers
A patient-focused research effort to find new ways to treat difficult thyroid cancers that no longer respond to current BRAF inhibitors.
-
Improving Treatment of Anaplastic Thyroid Cancer with New Therapies and Early Response Checks
This NIH grant aims to advance treatment for a rare, aggressive thyroid cancer by testing new approaches and measuring how tumors respond early in treatment to tailor care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.